Regulatory News
Friday, July 15, 2016
UPDATE 1-Cancer patient dies after Ziopharm experimental drug therapy
July 15 (Reuters) - Ziopharm Oncology Inc said a
brain cancer patient died of cranial bleeding about two weeks
after starting treatment with the gene therapy developer's lead
experimental drug,...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment